Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of NLRP3 Inflammasomes in Atherosclerosis
Tadayoshi Karasawa, Masafumi Takahashi
Journal of Atherosclerosis and Thrombosis (2017) Vol. 24, Iss. 5, pp. 443-451
Open Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Irene Maeve Rea, David S. Gibson, Victoria McGilligan, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 1049
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Daniel Frank, James E. Vince
Cell Death and Differentiation (2018) Vol. 26, Iss. 1, pp. 99-114
Open Access | Times Cited: 876
Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis
Xianxian Wu, Haiying Zhang, Wei Qi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 484
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
Marie A.C. Depuydt, Koen H.M. Prange, Lotte Slenders, et al.
Circulation Research (2020) Vol. 127, Iss. 11, pp. 1437-1455
Open Access | Times Cited: 414
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
R. Preston Mason, Peter Libby, Deepak L. Bhatt
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 5, pp. 1135-1147
Open Access | Times Cited: 317
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
Khadijeh Koushki, Sanaz Keshavarz Shahbaz, Kazem Mashayekhi, et al.
Clinical Reviews in Allergy & Immunology (2020) Vol. 60, Iss. 2, pp. 175-199
Open Access | Times Cited: 280
NLRP3 Inflammasome and Inflammatory Diseases
Zheng Wang, Simei Zhang, Ying Xiao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 279
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease
Fabrice Bonnet, André Scheen
Diabetes & Metabolism (2018) Vol. 44, Iss. 6, pp. 457-464
Closed Access | Times Cited: 262
Pathogenesis of Atherosclerosis: A Multifactorial Process
L. Maximilian Buja
Springer eBooks (2023), pp. 15-37
Closed Access | Times Cited: 243
The NLRP3 Inflammasome and Its Role in Sepsis Development
Lucinéia Gainski Danielski, Amanda Della Giustina, Sandra Bonfante, et al.
Inflammation (2019) Vol. 43, Iss. 1, pp. 24-31
Closed Access | Times Cited: 199
NLRP3 inflammasome as a key driver of vascular disease
Masafumi Takahashi
Cardiovascular Research (2021) Vol. 118, Iss. 2, pp. 372-385
Open Access | Times Cited: 131
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin Lin, Mu-xin Zhang, Lei Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 112
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials
Lucia Scisciola, Vittoria Cataldo, Fatemeh Taktaz, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 82
The role of NOD-like receptors in innate immunity
Cássio Luiz Coutinho Almeida-da-Silva, Luiz Eduardo Baggio Savio, Robson Coutinho‐Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 68
NLRP3: A Novel Mediator in Cardiovascular Disease
Wenyi Zhou, Chun‐Yuan Chen, Zhiheng Chen, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-8
Open Access | Times Cited: 161
New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease
R. Preston Mason
Current Atherosclerosis Reports (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 123
Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low‐grade inflammation the neglected component?
Francesco Prattichizzo, Valeria De Nigris, Stefano Micheloni, et al.
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 11, pp. 2515-2522
Closed Access | Times Cited: 103
Role of the NLRP3 Inflammasome in Preeclampsia
Koumei Shirasuna, Tadayoshi Karasawa, Masafumi Takahashi
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 97
Mechanisms of NLRP3 priming in inflammaging and age related diseases
Anna Gritsenko, Jack Green, David Brough, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 55, pp. 15-25
Open Access | Times Cited: 96
Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling
Xian Deng, Wei Huang, Juan Peng, et al.
Inflammation (2017) Vol. 41, Iss. 1, pp. 260-275
Closed Access | Times Cited: 92
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway
Shuang Xu, Hangwei Chen, Huaner Ni, et al.
Atherosclerosis (2020) Vol. 317, pp. 1-9
Closed Access | Times Cited: 92
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
Max J. M. Silvis, Evelyne J. Demkes, Aernoud T.L. Fiolet, et al.
Journal of Cardiovascular Translational Research (2020) Vol. 14, Iss. 1, pp. 23-34
Open Access | Times Cited: 89
Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis
Xiaoyan Lin, Siyu Ouyang, Chenxi Zhi, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 715, pp. 109098-109098
Closed Access | Times Cited: 89
GSDME-Dependent Incomplete Pyroptosis Permits Selective IL-1α Release under Caspase-1 Inhibition
Emi Aizawa, Tadayoshi Karasawa, Sachiko Watanabe, et al.
iScience (2020) Vol. 23, Iss. 5, pp. 101070-101070
Open Access | Times Cited: 79
Innate Immune Receptors, Key Actors in Cardiovascular Diseases
Rafael I. Jaén, Almudena Val‐Blasco, Patricia Prieto, et al.
JACC Basic to Translational Science (2020) Vol. 5, Iss. 7, pp. 735-749
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top